Nature CommunicationsCancer BiologyPeer-reviewed journal article
TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in Triple-Negative Breast Cancer
Nicholas SimiD, Jean-Michel CarteriD, Kamalakshi DekaiD, Benita Kiat Tee TaniD, Yirong SimiD, Suet‐Mien TaniD, Yinghui LiiD
Abstract
Triple Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype suffering from limited targeted treatment options. Following recent reports correlating Fn14 receptor overexpression in ER-negative breast cancers with metastatic events, we show that Fn14 is specifically overexpressed in TNBC patients and associated with poor survival. We demonstrate that constitutive Fn14 signalling rewires the transcriptomic and epigenomic landscape of TNBC, leading to enhanced tumour growth and metastasis. We further illustrate that such mechanisms activate TNBC-specific super enhancers (SE) to drive the transcriptional activation of cancer dependency genes via chromatin looping. In particular, we uncover the SE-driven upregulation of NAMPT, which promotes NAD+ and ATP metabolic reprogramming critical for filopodia formation and metastasis. Collectively, our study details the complex mechanistic link between TWEAK/Fn14 signalling and TNBC metastasis, which reveals several vulnerabilities which could be pursued for the targeted treatment of TNBC patients.
- organism: human
- assay: bulk RNA-seq
- assay: ChIP-seq
- research focus: cancer & tumor microenvironment
- research focus: chromatin & epigenetic regulation
- research focus: metabolism & bioenergetics
- approach: experimental assay
- approach: statistical model
- Citations
- 37
- FWCI
- 5.41
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NPC1 confers metabolic flexibility in Triple Negative Breast Cancer
K. I. O'Neill, L.-W. Kuo, … J. K. Richer·bioRxiv·May 5, 2022
- MNRR1 is required for Triple Negative Breast Cancer growth and metastasis and can be targeted by repurposed drugs.
Mrunal Sathe, Paige M. Minchella, … Siddhesh Aras·bioRxiv·Feb 3, 2026
- H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
- ACSL4 activity drives TNBC metastasis by positively regulating Histone H3 Acetylation mediated SNAIL expression
A. Sinha, K. K. Saini, … D. Datta·bioRxiv·Oct 16, 2023
- Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBC
Ramon Garcia‐Areas, Elodie Girard, … Thierry Dubois·Scientific ReportsPeer-reviewed·Apr 2, 2026
- De novo lipogenesis controls antigen presentation and metastatic immune escape in triple-negative breast cancer.
Myung Soo Ko, Henry Withers, … Vivek Mittal·bioRxiv·Oct 30, 2026